Zhong‐Zhe Lin

Specific <i>EGFR</i> Mutations Predict Treatment Outcome of Stage IIIB/IV Patients With Chemotherapy-Naive Non–Small-Cell Lung Cancer Receiving First-Line Gefitinib Monotherapy

Chong‐Jen Yu, Jin‐Yuan Shih, Yeun‐Chung Chang et al. · Journal of Clinical Oncology · 2008 · 240 citations

Medicine, Oncology, Pharmacology +17

Early alpha‐fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma

Yu‐Yun Shao, Zhong‐Zhe Lin, Chiun Hsu et al. · Cancer · 2010 · 173 citations

Medicine, Oncology, Pharmacology +15

Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma

Chih‐Hung Hsu, Chih‐Hung Hsu, Ying‐Chun Shen et al. · Journal of Hepatology · 2010 · 127 citations

Medicine, Oncology, Pharmacology +14

Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC

Zhong‐Zhe Lin, Yung‐Ming Jeng, Fu‐Chang Hu et al. · BMC Cancer · 2010 · 122 citations · Full text

Medicine, Cancer Biology, Oncology +15

Early alpha‐foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma

Yu‐Yun Shao, Tsung‐Hao Liu, Chiun Hsu et al. · Liver International · 2019 · 110 citations

Medicine, Immunology, Oncology +17